EMA recommends sale suspension of medicines based on GVK Bio's 'flawed ...

The European Medicines Agency has recommended suspension of sale of around 700 medicines whose authorization was given based on clinical trial conducted by Hyderabad India based GVK Biosciences GVK Bio The European drug regulator said that EMA recommends sale suspension of medicines based on GVK Bio's 'flawed ...

ema recommends hundreds of drugs to be suspended over 'flawed studies' - blogs.wsj.com the european medicines agency recommends suspending the sale of hundreds of drugs that were authorized for use across the continent based on flawed clinical studies that were conducted by gvk biosciences a clinical research organization based in

ema recommends suspending gvk biosciences medicines over flawed studies - pharmpro.com a number of medicines for which authorization in the european union eu was primarily based on clinical studies conducted at gvk biosciences in hyderabad india should be suspended says the european medicines agency ema the recommendation

gvk's trials doctored, stop drugs' sale: european body - timesofindia.indiatimes.com new delhi the european medicines agency ema has recommended suspension of the sale of hundreds of medicines for which authorization was given on the basis of clinical studies conducted at gvk biosciences in hyderabad the decision was taken

ema recommends suspending drugs over gvk data integrity issues - raps.org the european medicines agency ema is recommending eu member states suspend products whose approval relied on clinical trials conducted at gvk biosciences in hyderabad india the agency cites concerns over systemic data manipulation alleged

german regulator hails ema's drugs suspension on gvk bio data - business-standard.com german drug regulator has welcomed the european medicine agency's ema decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by india's gvk biosciences the move is being seen as the eu's

brazil allows import, sale of cannabis-based medicine - brazilbusiness.einnews.com rio de janeiro jan 15 bernamannnxinhua anvisa brazil's national health surveillance agency announced on wednesday that it will no longer forbid the sale of medicine containing cannabidiol a cannabisbased substance in the country

eu regulator recommends suspension of drugs over gvk bio data - economictimes.indiatimes.com london the european drug regulator has recommended suspension of a number of medicines whose authorisation was mainly based on the clinical trials conducted by hyderabadbased gvk biosciences "a number of medicines for which authorisation

european union regulator recommends suspension of drugs over gvk ... - financialexpress.com the european drug regulator has recommended suspension of a number of medicines whose authorisation was mainly based on the clinical trials conducted by hyderabadbased gvk biosciences a number of medicines for which authorisation in the

suspend dozens of drugs based on flawed studies, ema says - medscape.com a committee of the european medicines agency ema has recommended suspending the sale of roughly four dozen generics for conditions such as diabetes depression and hypertension because their approvals were based on flawed clinical studies

european drug regulator recommends suspending sales of some drugs - wsj.com europe's main pharmaceutical regulator recommended suspending the sale of hundreds of drug formulations that were approved for use based on flawed clinical studies conducted by gvk biosciences a clinical research organization in hyderabad india

View more